全文获取类型
收费全文 | 128838篇 |
免费 | 8252篇 |
国内免费 | 769篇 |
专业分类
耳鼻咽喉 | 1379篇 |
儿科学 | 5461篇 |
妇产科学 | 1889篇 |
基础医学 | 7583篇 |
口腔科学 | 4662篇 |
临床医学 | 13712篇 |
内科学 | 15794篇 |
皮肤病学 | 631篇 |
神经病学 | 12018篇 |
特种医学 | 36917篇 |
外国民族医学 | 1篇 |
外科学 | 20269篇 |
综合类 | 2741篇 |
现状与发展 | 5篇 |
一般理论 | 8篇 |
预防医学 | 1953篇 |
眼科学 | 799篇 |
药学 | 1582篇 |
7篇 | |
中国医学 | 110篇 |
肿瘤学 | 10338篇 |
出版年
2023年 | 5046篇 |
2022年 | 8057篇 |
2021年 | 9187篇 |
2020年 | 9101篇 |
2019年 | 6065篇 |
2018年 | 7365篇 |
2017年 | 7129篇 |
2016年 | 6942篇 |
2015年 | 7328篇 |
2014年 | 14219篇 |
2013年 | 11658篇 |
2012年 | 5211篇 |
2011年 | 3142篇 |
2010年 | 7013篇 |
2009年 | 5895篇 |
2008年 | 2162篇 |
2007年 | 2494篇 |
2006年 | 1874篇 |
2005年 | 1445篇 |
2004年 | 1209篇 |
2003年 | 1102篇 |
2002年 | 1050篇 |
2001年 | 1360篇 |
2000年 | 1071篇 |
1999年 | 1105篇 |
1998年 | 1053篇 |
1997年 | 730篇 |
1996年 | 888篇 |
1995年 | 762篇 |
1994年 | 639篇 |
1993年 | 521篇 |
1992年 | 354篇 |
1991年 | 321篇 |
1990年 | 355篇 |
1989年 | 293篇 |
1988年 | 394篇 |
1987年 | 180篇 |
1986年 | 174篇 |
1985年 | 288篇 |
1984年 | 314篇 |
1983年 | 411篇 |
1982年 | 253篇 |
1981年 | 268篇 |
1980年 | 224篇 |
1979年 | 147篇 |
1978年 | 154篇 |
1977年 | 112篇 |
1976年 | 130篇 |
1975年 | 141篇 |
1974年 | 106篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
71.
《The Canadian journal of cardiology》2022,38(1):49-58
BackgroundDilated cardiomyopathy (DCM) is a well described entity for heart failure (HF) with reduced left ventricular ejection fraction (LVEF). Recently, drugs and other substance of abuse have been recognised as potential triggers for DCM. The aim of this study was to assess the survival in patients ≤ 65 years of age with toxic cardiomyopathy (TCM). Left ventricular remodelling and the potential usefulness of left ventricular assist devices (LVADs) was also assessed.MethodsThis was a single-centre retrospective study from January 2003 to August 2019 of 553 patients ≤ 65 years old with LVEF < 40% at a tertiary-care cardiology centre.ResultsA total of 201 patients (36%) had a diagnosis of idiopathic DCM. Further analysis identified 38 patients (19%) for which a TCM was the most likely etiology (amphetamine [50%], cocaine [37%], anabolic steroids [8%], and energy drinks [5%]). Despite a mean LVEF of 17 ± 8% at presentation, most patients (n = 27; 71%) had event-free survival with guideline-directed medical therapy, and 61% (n = 23) recovered an LVEF ≥ 40% after a median follow-up of 21 ± 23 months. Seven patients (18%) required an LVAD and 1 patient (3%) a transplantation. All LVADs were explanted or decommissioned after partial or complete LVEF recovery after a median support time of 11 ± 4 months.ConclusionsTCM induced by substance abuse is a frequent cause of HF, accounting for almost 20% of patients ≤ 65 years of age with DCM of unknown etiology. Treatment must be tailored on an individual basis. Mechanical circulatory support demonstrated its usefulness in carefully selected patients. 相似文献
72.
《European journal of medical genetics》2022,65(6):104495
Spondyloepimetaphyseal dysplasias (SEMDs) belong to a clinically and genetically heterogeneous group of inherited skeletal disorders defined by a defect in the growth and shape of vertebrae, epiphyses and metaphyses. Rhizomelic SEMD is characterized by a disproportionate small stature caused by severe shortening and deformation of the limbs’ proximal bones, with the cranio-facial sphere unaffected. We report a second individual, an 8-year-old girl, with autosomal recessive rhizomelic SEMD associated with a homozygous exonic missense variant, c.226G > A p.(Glu76Lys), in GNPNAT1 identified by trio genome sequencing. Our data corroborate the recent findings of Ain et al. and further delineate the clinical and radiographic features of this form of SEMD associated with rhizomelic dysplasia while outlining a potential hotspot in this newly described genetic disorder. 相似文献
73.
74.
75.
76.
77.
78.
《Current problems in cardiology》2022,47(10):101297
Atrial fibrillation (AF) has a strong impact on the quality of life (QOL) of patients and anticoagulation has a lot to do with it. We evaluated the QOL of patients with nonvalvular AF who start treatment with apixaban in Latin America. QOL was analyzed through a questionnaire developed to evaluate anticoagulated patients, which was completed by them 3 months after starting treatment. We included 521 patients from Uruguay, Bolivia, Ecuador, Paraguay, and Peru. A high index of general treatment satisfaction (5.34 ± 0.46) and self-efficacy (5.11 ± 0.68) were observed; the distress index was low (1.77 ± 0.88), as was the perception of daily hassles (1.35 ± 0.49) and strain social network related to medication (1.21 ± 0.34). Patients with AF who started treatment with apixaban has good satisfaction and self-efficacy scores with low index of stress, few daily limitations and social disruptions. 相似文献
79.
《Practical radiation oncology》2022,12(6):e512-e516
Stereotactic body radiation therapy (SBRT) is commonly used to treat early-stage non-small cell lung cancer. Beam arrangements for SBRT include multiple entry and exit pathways resulting in irregular low-dose distributions within normal lung parenchyma. An improved understanding of posttreatment radiographic changes may improve the ability to predict clinical complications including radiation pneumonitis as well as assist in early detection of local failures. Radiation treatment planning is conducted using software systems separate from diagnostic radiology, often not accessible to the diagnostic radiologist. We developed a workflow for interfacing radiation dose information from lung SBRT treatments with a diagnostic radiology picture archiving and communication system (PACS). In an anonymized PACS study folder, SBRT dose maps depicting high-dose, low-dose, and nonirradiated lung volumes were viewable side by side with pretreatment and follow-up diagnostic computed tomography scans. Clinical utility was evaluated by 2 thoracic diagnostic radiologists reviewing posttreatment diagnostic follow-up scans in the PACS both with and without radiation dose maps available. The addition of the biologically effective dose map did not significantly change identification rates of radiation induced lung injury) (92% vs 95%; P = .32) but did significantly decrease radiologic suspicion for local recurrence (22% vs 8%; P = .003). The addition of biologically effective dose maps significantly increased confidence in identifying radiation induced lung injury (7.75 vs 8.82; P = .004) and local recurrence (5.5 vs 6.6; P = .005). The recommendation for additional workup was not significantly different (10% vs 7%; P = .41). We demonstrated the feasibility and clinical utility of a workflow generating simplified radiation dose maps that are viewable within a PACS for diagnostic radiology review. 相似文献
80.
《The lancet oncology》2022,23(1):125-137